However, Krawczyk et al. reported that TM6SF2 variant as well as PNPLA3 variation did not impair the response to low-calorie four-month dietetic intervention in 143 NAFLD patients [71]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.